·RBI relaxes norms for lending against gold jewellery
RBI has relaxed the norms for NBFCs (lending against gold) by allowing to use the historical spot gold price data publicly disseminated by a commodity exchange regulated by the Forward Markets Commission for valuation of gold for LTV calculation. Earlier RBI had allowed valuation of gold jewellery for arriving at the LTV to be done at the average of the closing price of 22 carat gold for the preceding 30 days as quoted by the Bombay Bullion Association Ltd. (BBA).
·Government relaxes FDI norms
Union Cabinet on has approved a relaxation of policy on investment proposals from Persons of Indian Origin (PIOs) and Overseas Citizens of India (OCIs), treating them at par with Non-Resident Indians ( NRIs) in this regard. The non-repatriable. NRI funds would also be treated as domestic investments. These measures will boost remittances and increase the inflows and hence positive for Indian economy.
·Wockhardt gets QIDP designation from USFDA for new drugs
Wockhardt, has announced the US Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) status for its drug under New Drug Discovery program WCK 4873. This is the third product from Wockhardt to receive this coveted status after WCK 771 and WCK 2349 last year and provides a strong boost to its drug development.
·Reliance-BP surrender two more oil and gas blocks
Reliance Industries and its partner BP plc have surrendered two more oil and gas blocks, taking total surrender of four exploration acreages from 21 they were holding – Sentimentally negative.
·Emami in final negotiations to buy Kesh King
According to media news, Emami has entered into final negotiations to buy Kesh King brand of SBS Biotech. Deal talks are hovering around a deal size of Rs1,800cr and the companies target to sign on the dotted line by May-end if talks succeed. Bajaj Corp also was in the race however, Emami has outpaced it.
·Suven Life secures One Product Patent each in Mexico and Singapore
Suven Life Sciences (Suven) announces today that the grant of one product patent from Mexico and one product patent from Singapore corresponding to the New Chemical Entities ( NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029.
·Adani Mining signs up buyers for coal mine in Australia
Adani Mining has signed up buyers for around 70 percent of the coal it plans to produce from a huge mine in Australia, putting it a step closer to being able to seal funding for the A$10 billion ($7.9 billion) project. Though it’s a positive development, the key hurdles ahead of the company is to secure loans for the Carmichael mine, rail and port project, dredging approval to expand its Abbot Point port.
·Ahluwalia Contracts gets Rs676 cr construction orders
Ahluwalia Contracts (India) said that it has bagged orders worth Rs676.36 crore for construction of institutional and residential buildings. The company has secured new orders aggregating Rs676.36 crore (approx) for construction of institutional/residential building, including electrical, plumbing and fire fighting services.
RBI has relaxed the norms for NBFCs (lending against gold) by allowing to use the historical spot gold price data publicly disseminated by a commodity exchange regulated by the Forward Markets Commission for valuation of gold for LTV calculation. Earlier RBI had allowed valuation of gold jewellery for arriving at the LTV to be done at the average of the closing price of 22 carat gold for the preceding 30 days as quoted by the Bombay Bullion Association Ltd. (BBA).
·Government relaxes FDI norms
Union Cabinet on has approved a relaxation of policy on investment proposals from Persons of Indian Origin (PIOs) and Overseas Citizens of India (OCIs), treating them at par with Non-Resident Indians ( NRIs) in this regard. The non-repatriable. NRI funds would also be treated as domestic investments. These measures will boost remittances and increase the inflows and hence positive for Indian economy.
·Wockhardt gets QIDP designation from USFDA for new drugs
Wockhardt, has announced the US Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) status for its drug under New Drug Discovery program WCK 4873. This is the third product from Wockhardt to receive this coveted status after WCK 771 and WCK 2349 last year and provides a strong boost to its drug development.
·Reliance-BP surrender two more oil and gas blocks
Reliance Industries and its partner BP plc have surrendered two more oil and gas blocks, taking total surrender of four exploration acreages from 21 they were holding – Sentimentally negative.
·Emami in final negotiations to buy Kesh King
According to media news, Emami has entered into final negotiations to buy Kesh King brand of SBS Biotech. Deal talks are hovering around a deal size of Rs1,800cr and the companies target to sign on the dotted line by May-end if talks succeed. Bajaj Corp also was in the race however, Emami has outpaced it.
·Suven Life secures One Product Patent each in Mexico and Singapore
Suven Life Sciences (Suven) announces today that the grant of one product patent from Mexico and one product patent from Singapore corresponding to the New Chemical Entities ( NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029.
·Adani Mining signs up buyers for coal mine in Australia
Adani Mining has signed up buyers for around 70 percent of the coal it plans to produce from a huge mine in Australia, putting it a step closer to being able to seal funding for the A$10 billion ($7.9 billion) project. Though it’s a positive development, the key hurdles ahead of the company is to secure loans for the Carmichael mine, rail and port project, dredging approval to expand its Abbot Point port.
·Ahluwalia Contracts gets Rs676 cr construction orders
Ahluwalia Contracts (India) said that it has bagged orders worth Rs676.36 crore for construction of institutional and residential buildings. The company has secured new orders aggregating Rs676.36 crore (approx) for construction of institutional/residential building, including electrical, plumbing and fire fighting services.
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. CapitalStras also ave liable on linke din and facebook. Get real time advice for Share Tips , Trading Strategies , Best Intraday Stocks , Stock Tips Free and all market updates. For 2 Days Free Trial ,Please visit our site http://www.capitalstars.com Call at 0731-6790000, 6669900.
0 comments:
Post a Comment